Constellation Pharmaceuticals (CNST) EV/EBITDA US GAAP (year values) |
||||||||
2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | |||
EV/EBITDA | ? | 0.80 | 0.36 | 1.13 | -11.8 | -3.20 | -9.01 | |
Changes by years, y/y, % | -55% | +211% | -1 148% | -73% |
Constellation Pharmaceuticals. EV/EBITDA
Constellation Pharmaceuticals. EV/EBITDA, changes, %
Constellation Pharmaceuticals (CNST) EV/EBITDA US GAAP (quarter values) |
||||||||
2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | 2021Q1 | LTM ? | |||
EV/EBITDA | ? | -11.0 | -8.09 | -4.61 | -7.75 | -5.35 | -9.01 | |
Changes by years, y/y, % | +193% | +160% | +244% | -59% | -51% | |||
Changes by quarters, q/q, % | -42% | -26% | -43% | +68% | -31% |